Page last updated: 2024-10-21

hydroxyindoleacetic acid and Diarrheogenic Islet Cell Tumor

hydroxyindoleacetic acid has been researched along with Diarrheogenic Islet Cell Tumor in 2 studies

(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.

Research Excerpts

ExcerptRelevanceReference
"Seventy-one patients were treated."2.71Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged-release formulation of lanreotide. ( Arnold, R; Bax, N; Caplin, M; de Herder, WW; Delle Fave, G; Ducreux, M; Eriksson, B; Glaser, B; Grossman, A; Ish-Shalom, S; Lombard-Bohas, C; O'Toole, D; Reed, N; Rougier, P; Ruszniewski, P; Schmidt, W; Seitz, JF; Tomassetti, P; Van Cutsem, E; Wiedenmann, B; Wymenga, M, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ruszniewski, P1
Ish-Shalom, S1
Wymenga, M1
O'Toole, D1
Arnold, R1
Tomassetti, P1
Bax, N1
Caplin, M1
Eriksson, B1
Glaser, B1
Ducreux, M1
Lombard-Bohas, C1
de Herder, WW1
Delle Fave, G1
Reed, N1
Seitz, JF1
Van Cutsem, E1
Grossman, A1
Rougier, P1
Schmidt, W1
Wiedenmann, B1
Blanchin, M1
James-Deidier, A1
Chaumet-Riffaud, PD1
Chayvialle, JA1

Trials

2 trials available for hydroxyindoleacetic acid and Diarrheogenic Islet Cell Tumor

ArticleYear
Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged-release formulation of lanreotide.
    Neuroendocrinology, 2004, Volume: 80, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Chromogranins; Delayed-Action Preparations; Dose-Response Relationsh

2004
[Use of octreotide in the treatment of digestive endocrine tumors. A French multicenter study].
    Presse medicale (Paris, France : 1983), 1992, Apr-18, Volume: 21, Issue:15

    Topics: Adult; Aged; Aged, 80 and over; Female; France; Gastrinoma; Glucagonoma; Humans; Hydroxyindoleacetic

1992